You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

134 Results
Drug
Other Name(s): Tarceva®
Oct 2022
Drug
Other Name(s): Cosmegen®
Jan 2022
Drug
Other Name(s): Tykerb®
Dec 2022
Drug
Other Name(s): BiCNU®
Oct 2022
Drug
Drug
Other Name(s): Xalkori®
Jan 2022
Drug
Other Name(s): Perjeta®
Sep 2022
Drug
Other Name(s): Zydelig™
Feb 2022
Regimen
Cancer Type:
Hematologic, 
Myelodysplastic Syndrome (MDS)
Intent: Palliative
Funding:
ODB Limited Use
    lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria
May 2022
Regimen
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Neoadjuvant, Adjuvant, Palliative
Sep 2022
Regimen
Cancer Type:
Breast, 
Central Nervous System, 
Gastrointestinal, 
Colorectal, 
Esophagus, 
Gastric / Stomach, 
Hepatobiliary / Liver / Bile Duct, 
Pancreas, 
Genitourinary, 
Bladder / Urothelial, 
Prostate, 
Gynecologic, 
Cervix, 
Endometrial, 
Ovary, 
Head and Neck, 
Lung, 
Small Cell
Intent: Palliative
Mar 2018
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    tamoxifen
May 2022

Pages